Compound: Lestaurtinib

Drug Target: FLT3, JAK2, NTRK1, NTRK2, NTRK3

Drug Target pathway: Other, kinases

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences



Tissue specific analysis

max conc.min conc.max conc.min conc.0.0010.010.11101001,0000.0010.010.11101001,000IC50Lestaurtinib (GDSC2)drug target: FLT3, JAK2, NTRK1, NTRK2, NTRK3IC50Lestaurtinib (GDSC2)drug target: FLT3, JAK2, NTRK1, NTRK2, NTRK3

Statistics

All cell lines
Number of cell lines 941
Pearson correlation 1.0000
Spearman correlation 1.0000

Chart settings

Colour dots by:


Display features:

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.